Effect of training and Momordica charantia L on diabetes

Effects of Moderate-Intensity Exercise with Momordica Charantia L. on serum Glycemic indexes, reverse cholesterol transport elements and Lipocalins (RBP-4 and Lcn-2) in Men with Type 2 Diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161218031451N2

Enrollment

Registered

2019-11-05

Start date

2019-09-06

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Control group: in this group we have not any intervention during 6 weeks, and will consider this group as placebo. Intervention 2: Intervention group: Training group (in this group for

Eligibility

Sex/Gender

Male

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Type 2 Diabetes Not having regular physical activity Without receive insulin At least 45 years old

Exclusion criteria

Exclusion criteria: Have Heart and Kidney failure Inability to Training Have Musculoskeletal Disorders

Design outcomes

Primary

Measure	Time frame
Effect of aerobic training and Momordica charantia L on GLP-1. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on GIP. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on DPP-4. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on Insulin Resistance. Timepoint: Before and after the protocol. Method of measurement: HOMA-IR METOD.;Effect of aerobic training and Momordica charantia L on APO-a1. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on APO-E. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on LCN-2. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on RBP4. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.	—

Measure

Time frame

Effect of aerobic training and Momordica charantia L on GLP-1. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on GIP. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on DPP-4. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on Insulin Resistance. Timepoint: Before and after the protocol. Method of measurement: HOMA-IR METOD.;Effect of aerobic training and Momordica charantia L on APO-a1. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on APO-E. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on LCN-2. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.;Effect of aerobic training and Momordica charantia L on RBP4. Timepoint: Before and after the protocol. Method of measurement: Biochemical and laboratory methods.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Abdi

Islamic Azad University

a.abdi@iauamol.ac.ir+98 11 4321 7126

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026